1.Clinical outcomes of gastric variceal obliteration using N-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage.
Chung Hwan JUN ; Ka Rham KIM ; Jae Hyun YOON ; Han Ra KOH ; Won Suk CHOI ; Kyu Man CHO ; Sung Uk LIM ; Chang Hwan PARK ; Young Eun JOO ; Hyun Soo KIM ; Sung Kyu CHOI ; Jong Sun REW
The Korean Journal of Internal Medicine 2014;29(4):437-444
BACKGROUND/AIMS: To evaluate the long-term efficacy and safety of endoscopic injection of N-butyl-2-cyanoacrylate (NBC; Histoacryl) for treatment of bleeding gastric varices. METHODS: We retrospectively analyzed the records of 455 patients with gastric variceal hemorrhage (GVH) who were consecutively treated with NBC from January 2004 to July 2013, with a mean follow-up period of 582 days. The patients' endoscopic findings, initial hemostasis, complications, rebleeding rates, and bleeding-related death rates were reviewed. RESULTS: Hemostasis was achieved initially in 96.9% (441/455) of patients; rebleeding occurred in 35.2% (160/455), and the bleeding-related death rate was 6.8% (31/455) during follow-up. Complications included fever (6.8%), abdominal pain (3.7%), diarrhea (1.3%), spontaneous bacterial peritonitis (0.7%), bacteremia (0.4%), and embolism (0.2%). A red-color sign on concomitant esophageal varices (EVs) (p = 0.002) and previous history of variceal bleeding (p < 0.001) were significant risk factors for rebleeding within 1 year. The Child-Pugh score (p < 0.001), presence of hepatocellular carcinoma (p = 0.001), and failure of initial hemostasis (p < 0.001) were the risk factors most closely associated with bleeding-related death. CONCLUSIONS: This study provides a comprehensive overview of the outcomes and prognostic factors of patients with GVH. The results may help in the selection of effective treatment strategies for patients with GVH.
Adult
;
Aged
;
Aged, 80 and over
;
Enbucrilate/adverse effects/*therapeutic use
;
Endoscopy, Gastrointestinal
;
Esophageal and Gastric Varices/complications/diagnosis/mortality/*therapy
;
Female
;
Gastrointestinal Hemorrhage/diagnosis/etiology/mortality/*therapy
;
*Hemostatic Techniques/adverse effects/mortality
;
Humans
;
Male
;
Middle Aged
;
Recurrence
;
Retrospective Studies
;
Time Factors
;
Treatment Outcome
;
Young Adult
2.Clinical Characteristics of Acute Upper Gastrointestinal Bleeding in a Tertiary Referral Center.
Chang Nyol PAIK ; In Seok LEE ; Jung Hwan OH ; Jae Myung PARK ; Yu Kyung CHO ; Sang Woo KIM ; Myung Gyu CHOI ; In Sik CHUNG
The Korean Journal of Gastroenterology 2007;50(1):26-35
BACKGROUND/AIMS: Acute upper gastrointestinal bleeding (UGIB) is still responsible for significant morbidity in spite of various therapeutic advances. The aims of this study were to evaluate the success rate in managing UGIB and predicting factors that affected clinical courses. METHODS: From August 2003 to April 2005, medical data (registered in a standard database categories) of 318 patients who underwent endoscopic examination to evaluate UGIB were analyzed. Early and final treatment success rates were evaluated on the next day and 14 days after the initial endoscopic procedures respectively (or the day of discharge). RESULTS: Main causes of UGIB were peptic ulcer (50.9%), varices (28.3%), Mallory-Weiss syndrome (10.3%). Endoscopic treatments were tried in 200 patients (63.0%). Number of patients who underwent operation and deaths were 4 (1.3%) and 13 (4.1%), respectively. Early and final success rates were 86.2% and 94.0%. Independent prognostic factors related with early success rates were volume of transfusion (OR 0.80, 95% CI 0.72-0.89, p<0.001) and bleeding during the ventilator care (OR 0.03, 95% CI 0.01-0.31, p<0.001), whereas those factors related with final success rates were volume of transfusion (OR 0.79, 95% CI 0.69-0.90, p<0.001), bleeding during the stay in intensive care unit (ICU) (OR 0.12, 95% CI 0.13-0.49, p<0.001). CONCLUSIONS: Early and final success rates of bleeding control were 86.2% and 94.0% in acute UGIB. Volume of transfusion, bleeding during ICU state or ventilator state were important predictive factors of the treatment failure.
Acute Disease
;
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Blood Transfusion
;
Data Interpretation, Statistical
;
Demography
;
Esophageal and Gastric Varices/*diagnosis/therapy
;
Female
;
Gastrointestinal Hemorrhage/*diagnosis/mortality/therapy
;
Humans
;
Male
;
Mallory-Weiss Syndrome/*diagnosis/therapy
;
Middle Aged
;
Peptic Ulcer/*diagnosis/therapy
;
Prognosis
;
Referral and Consultation
;
Retrospective Studies
;
Treatment Outcome
3.Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?.
Ka Rham KIM ; Chung Hwan JUN ; Kyu Man CHO ; Jin Woo WI ; Seon Young PARK ; Sung Bum CHO ; Wan Sik LEE ; Chang Hwan PARK ; Young Eun JOO ; Hyun Soo KIM ; Sung Kyu CHOI ; Jong Sun REW
The Korean Journal of Internal Medicine 2015;30(5):593-601
BACKGROUND/AIMS: To evaluate the efficacy of proton pump inhibitors (PPIs) in reducing rebleeding and bleeding-related death rates after endoscopic gastric variceal obliteration (GVO) using N-butyl-2-cyanoacrylate (NBC). METHODS: This study enrolled 341 patients who were consecutively diagnosed with and treated for bleeding gastric varices. The patients were divided into PPI and non-PPI groups, and their endoscopic findings, initial hemostasis outcomes, rebleeding and bleeding-related death rates, and treatment-related complications were analyzed. RESULTS: The rate of initial hemostasis was 97.1%. rebleeding occurred in 2.2% of patients within 2 weeks, 3.9% of patients within 4 weeks, 18.9% of patients within 6 months, and 27.6% of patients within 12 months of the GVO procedure. A previous history of variceal bleeding (relative risk [RR], 1.955; 95% confidence interval [CI], 1.263 to 3.028; p = 0.003) and use of PPIs (RR, 0.554; 95% CI, 0.352 to 0.873; p = 0.011) were associated with rebleeding. Child-Pugh class C (RR, 10.914; 95% CI, 4.032 to 29.541; p < 0.001), failure of initial hemostasis (RR, 13.329; 95% CI, 2.795 to 63.556; p = 0.001), and the presence of red-colored concomitant esophageal varices (RR, 4.096; 95% CI, 1.320 to 12.713; p = 0.015) were associated with bleeding-related death. CONCLUSIONS: The prophylactic use of PPIs reduces rebleeding after GVO using NBC in patients with gastric variceal hemorrhage. However, prophylactic use of PPIs does not reduce bleeding-related death.
Adult
;
Aged
;
Aged, 80 and over
;
Chi-Square Distribution
;
Enbucrilate/*administration & dosage/adverse effects
;
Endoscopy, Gastrointestinal
;
Esophageal and Gastric Varices/complications/diagnosis/mortality/*therapy
;
Female
;
Gastrointestinal Hemorrhage/diagnosis/etiology/mortality/*therapy
;
Hemostasis, Endoscopic/adverse effects/*methods/mortality
;
Humans
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Proton Pump Inhibitors/adverse effects/*therapeutic use
;
Recurrence
;
Retrospective Studies
;
Risk Factors
;
Sclerosing Solutions/*administration & dosage/adverse effects
;
Sclerotherapy/adverse effects/*methods/mortality
;
Time Factors
;
Treatment Outcome
;
Young Adult
4.Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data.
Moon Young KIM ; Soon Ho UM ; Soon Koo BAIK ; Yeon Seok SEO ; Soo Young PARK ; Jung Il LEE ; Jin Woo LEE ; Gab Jin CHEON ; Joo Hyun SOHN ; Tae Yeob KIM ; Young Suk LIM ; Tae Hyo KIM ; Tae Hee LEE ; Sung Jae PARK ; Seung Ha PARK ; Jin Dong KIM ; Sang Young HAN ; Chang Soo CHOI ; Eun Young CHO ; Dong Joon KIM ; Jae Seok HWANG ; Byoung Kuk JANG ; June Sung LEE ; Sang Gyune KIM ; Young Seok KIM ; So Young KWON ; Won Hyeok CHOE ; Chang Hyeong LEE ; Byung Seok KIM ; Jae Young JANG ; Soung Won JEONG ; Byung Ho KIM ; Jae Jun SHIM ; Yong Kyun CHO ; Moon Soo KOH ; Hyun Woong LEE
Clinical and Molecular Hepatology 2013;19(1):36-44
BACKGROUND/AIMS: While gastric variceal bleeding (GVB) is not as prevalent as esophageal variceal bleeding, it is reportedly more serious, with high failure rates of the initial hemostasis (>30%), and has a worse prognosis than esophageal variceal bleeding. However, there is limited information regarding hemostasis and the prognosis for GVB. The aim of this study was to determine retrospectively the clinical outcomes of GVB in a multicenter study in Korea. METHODS: The data of 1,308 episodes of GVB (males:females=1062:246, age=55.0+/-11.0 years, mean+/-SD) were collected from 24 referral hospital centers in South Korea between March 2003 and December 2008. The rates of initial hemostasis failure, rebleeding, and mortality within 5 days and 6 weeks of the index bleed were evaluated. RESULTS: The initial hemostasis failed in 6.1% of the patients, and this was associated with the Child-Pugh score [odds ratio (OR)=1.619; P<0.001] and the treatment modality: endoscopic variceal ligation, endoscopic variceal obturation, and balloon-occluded retrograde transvenous obliteration vs. endoscopic sclerotherapy, transjugular intrahepatic portosystemic shunt, and balloon tamponade (OR=0.221, P<0.001). Rebleeding developed in 11.5% of the patients, and was significantly associated with Child-Pugh score (OR=1.159, P<0.001) and treatment modality (OR=0.619, P=0.026). The GVB-associated mortality was 10.3%; mortality in these cases was associated with Child-Pugh score (OR=1.795, P<0.001) and the treatment modality for the initial hemostasis (OR=0.467, P=0.001). CONCLUSIONS: The clinical outcome for GVB was better for the present cohort than in previous reports. Initial hemostasis failure, rebleeding, and mortality due to GVB were universally associated with the severity of liver cirrhosis.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Asian Continental Ancestry Group
;
Endoscopy
;
Esophageal and Gastric Varices/*diagnosis/mortality/therapy
;
Female
;
*Gastrointestinal Hemorrhage
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prognosis
;
Republic of Korea
;
Retrospective Studies
;
Sclerotherapy
;
Severity of Illness Index
;
Treatment Outcome
;
Young Adult